Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Semcon wins framework agreement with Getinge

Semcon has signed a new three-year framework agreement with Getinge regarding technical consulting services within life science, covering both product and production development.With more than 35 years of experience in life science, Semcon supports customers in developing user-friendly medical devices, quality-assured pharmaceuticals, and efficient digital information solutions. “We look forward to continuing to support Getinge in their important work. This new agreement means great opportunities for us at Semcon, especially in Stockholm and Växjö, but also in Gothenburg and Getinge's

Invitation to presentation of Ranplan’s H1 interim report 2022

Stockholm, Sweden, 18 August 2022 – Ranplan Group AB is pleased to invite media, investors, shareholders and financial analysts to a video conference meeting from its office in the city of Stockholm. On this occasion, CEO Per Lindberg and CSO Jon Ullmark will present the report for the first six months of 2022. Those who want to participate online at this event should notify the company of their interest before 6pm CET on 24 Aug 2022 by sending an e-mail to joyce.wu@ranplanwireless.com (joyce.wu@ranplanwireless.com?subject=2022%20H1%20Interim%20Report%20Invitation). On the morning of 25

The exercise period for warrants of series TO 1 begins today

Today, 18 August 2022, marks the beginning of the exercise period for warrants of series TO 1, that were issued in connection with CS MEDICA A/S’s (“CS MEDICA” or the “Company”) issue of units that took place in September 2021. The exercise period runs until and including 1 September 2022. Upon full exercise of warrants of series TO 1, CS MEDICA will receive approx. DKK 10.8 million before deduction of transaction related costs. An information document and subscription forms are available on the websites of CS MEDICA (www.cs-medica.com), Sedermera Corporate Finance AB (www.sedermera.se) and

TG’s favorite model is renewed

The TG 5.9 has been Finland’s best-selling cabin boat for several years. Now TG boats is launching a new model, TG 6.1, based on the favorite model. The timeless design and the glued windshield make the TG 6.1 modern and stylish. The new TG 6.1 will be shown for the first time at the Floating boat show in Helsinki on August 18-21.The TG 6.1 follows the modern design known from the other TG boats. The boat’s high sides, practically shaped bow and extensive railings make it comfortable and safe to move around on the foredeck for both children and adults. The front rails are attached with

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 158 - 18 AUGUST 2022 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 40 million (approximately DKK 290 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 15% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was granted at NORDEN’s general meeting on 24 March 2022.   Purpose The purpose of the share

Interim report Q2, 2022

Second quarter · Net sales amounted to SEK 21.8 (14.1) million · EBITDA* amounted to SEK -0.4 (-1.5) million · EBIT amounted to SEK –16.9 (-21.9) million   · EBT amounted to SEK -20.0 (-23.8) million · Earnings per share before dilutions amounted to -0,05 (-0.08) Significant events during the reporting period · Ampilio signs partnership agreement with Atlas Copco · Google Digitalakademin has chosen to renew its collaboration with Ampilio, subsidiary of SpectrumOne · Johan Holmberg appointed interim CEO of SpectrumOne AB · Observit AB, a subsidiary of

Half year Report January - June 2022

April – June 2022- Net Sales MSEK 124.5 (125.8)- Order intake MSEK 239.7 (46.9)- Operating profit (EBITDA) MSEK 17.7 (13.5)- Operating profit (EBIT) MSEK 7.1 (4.6)- Total Comprehensive income MSEK 27.5 (-1.0)- Earnings per share, before and after dilution (SEK) 0.01 (0.00)- Cash flow from operating activities MSEK 30.8 (38.2) January – June 2022- Net Sales MSEK 237.9 (203.9)- Order intake MSEK 323.2 (108.7)- Operating profit (EBITDA) MSEK 33.3 (8.0)- Operating profit (EBIT) MSEK 12.7 (-9.6)- Total Comprehensive income MSEK 39.8 (-2.0)- Earnings per share, before

Qlife updates vision and websites – Reinforced emphasis on making Egoo Health available for home use

Qlife today presents an updated vision and new websites for corporate and IR communication as well as for the company’s diagnostics self-testing platform Egoo Health. The objective is to emphasize the foundation of Qlife’s purpose to help improve quality of life for every individual and for the future society by making Egoo Health available for home use.Qlife was founded based on the idea that Egoo Health could help people lead a better life by using the diagnostics self-testing platform Egoo Health. Today, the short-term focus is on completing product development and approvals for CRP (

CS MEDICA A/S: CFO Gitte Lund Henriksen buys more shares in the Company

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CFO of the Company, Gitte Lund Henriksen, has acquired 2 500 shares in CS MEDICA through several transactions, at an average price of 10,75, amounting to a total value of 27 250 DKK.CFO and board member of CS MEDICA, Gitte Lund Henriksen, has purchased 2 500 shares in the open market at an average price of DKK 10,75 per share, corresponding to a total purchase of 27 250 DKK. The transaction has been disclosed in the Danish financial supervisory register. Following the transaction, Gitte Lund Henriksen owns 4 039 500 CS

ExpreS2ion announces financial results for the second quarter 2022

Hørsholm, Denmark, August 18, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its second quarter financial results for 2022. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “During the second quarter of 2022, we continued to deliver strong progress in our key pipeline projects, as well as in the overall company development. We see excellent potential in our ongoing efforts to move ExpreS[2]ion higher up in the value chain by developing our own pipeline projects.

Minesto publishes Half-Year Report 2022

CEO Dr Martin Edlund: “There are immediate opportunities where our small scale systems and competitive LCOE profile make a difference”.Significant events April-June 2022 · In April, Minesto launched a build-out plan for tidal energy arrays in the Faroe Islands. The plan includes four new verified sites with the potential to supply 40 percent of the country's growing electricity consumption, enabling the Faroe Islands to reach their policy goal of 100 percent renewable energy by 2030. Together with the local electricity company SEV, Minesto has presented the plan to a wide range of

Axel Schörling has, in accordance with the plan, started as new CEO in EQL Pharma AB and Martin Kristoffersson is appointed new COO.

Christer Fåhraeus, Founder & CEO, notified the Board in the autumn of 2021 that he intends to transition into a Board position after the Annual General Meeting (“AGM”) in August 2022. At that time, the Board appointed Axel Schörling, Deputy CEO, as new CEO after Fåhraeus´ resignation following the AGM in August 2022. After todays AGM, Schörling has assumed the position as new CEO in EQL. In connection with this, Martin Kristofferson, previously Director Strategic Sourcing, has been appointed new COO.Christer Fåhraeus, new Chairman of the Board, will remain a dedicated and committed main

Lumito publishes Quarterly Report 2, 2022

First half of the year 1 January–30 June 2022 · Net sales amounted to KSEK 0 (0). · Result after taxes amounted to KSEK -13,610 (-13,444). · Basic and diluted earnings per share amounted to SEK -0.09 (-0.15) · Cash flow from operating activities after change in working capital amounted to KSEK -14,636 (-12,883). · Cash and cash equivalents amounted to KSEK 32,275 (18,120) on the balance sheet date. Financial overview of the second quarter, 1 April to 30 June 2022 · Net sales amounted to KSEK 0 (0). · Result after taxes amounted to KSEK -7,180 (-6,619). ·

Interim financial report for the period 1 January – 30 June 2022 and adjusted financial outlook for 2022

Company Announcement 32/2022 First half of 2022 was characterised by historically challenging markets with distressed supply chains and high-cost inflation. Q2 2022 margins were pressured by immediate surcharges from suppliers, while adjustments to sales prices are expected to positively impact margins in H2 2022. Demand for newbuilds have decreased and the lower sales levels are expected to continue. A reorganisation is initiated on 18 August. Outlook for 2022 is adjusted due to lower expected sales for 2022, delayed effect of sales price adjustments and special items in relation to

NORDEN achieves fantastic Q2 result and pays interim dividend to shareholders

ANNOUNCEMENT NO. 157 - 18 AUGUST 2022 For Q2 2022 NORDEN reports a profit of USD 179 million (approx. DKK 1.3 bill.) (Q2 2021: USD 32 million - approx. DKK 233 mill.). Cash flow from operating activities amount to approx. USD 350 mill. (approx. DKK 2.6 bill.).   NORDEN CEO, Jan Rindbo, comments: “Fantastic second quarter result based on a significant shift in market exposure from dry cargo to product tankers. This has enabled NORDEN to capitalise on the exceptional product tanker rates, while also generating value in a weakening dry cargo market from an extensive cargo and cover

TORM plc Second Quarter and Half-Year Report 2022

“In the second quarter of 2022, TORM realized TCE rates which were more than twice as high as in the same period of 2021, resulting in an EBITDA of USD 153m and a profit before tax of USD 107m. This enables TORM to distribute USD 47m to our shareholders as dividends,” says Executive Director Jacob Meldgaard, and continues “The market has continued to improve into the third quarter of 2022, and so far, we have achieved rates which are more than three times as high as those we achieved in the third quarter of 2021.”· In the second quarter of 2022, TORM achieved TCE rates of USD/day 29,622 (

H+H International AS H1 2022 Interim Financial Report

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Company”) has adopted the Interim Financial Report for the second quarter (“Q2 2022”) and the first six months of 2022 (“H1 2022”). CHIEF EXECUTIVE OFFICER MICHAEL T. ANDERSEN QUOTE “This was an exceptionally strong quarter for H+H fuelled by continued high activity and customer demand. I am pleased with the solid performance across the business in the first half of 2022, which demonstrates our continued ability to negotiate sales price increases with customers to offset the continued

Bricknode interim report January - June 2022

Bricknode has today published its interim report for the period January – June 2022. The report is attached to this press release and is available on the company’s website .Q2 2022 in brief · Net revenue increased by 25% to 4,473 (3,589) TSEK · Net revenue retention rate 101% (110%) · Earnings per share amounted to -0,53 (-0,26) SEK · EBIT result amounted to -5,154 (-2,001 TSEK) and the margin amounted to -115% (-56%) Comments from the CEOs, Stefan Willebrand & Erik Hagelin “The financial markets have been

Flexion expands into TikTok – through its subsidiary Audiencly and investment in Liteup Media

LONDON  18th of August, 2022.  Flexion Mobile’s wholly owned influencer marketing agency Audiencly is transforming many of its 6000 - 7000 top influencers on to TikTok using Liteup Media’s disruptive service, a company Flexion recently invested in. The recently launched cost per install (CPI) service offers game developers a way to target users on Tiktok, and works in a similar way to automated ad buying. TikTok is currently the fastest growing social media platform and, importantly for game developers, the best for reaching Generation Z (zoomers) — 10 to 25-year-olds, the biggest

Interim report January – June 2022

SATISFACTORY RESULTS IN A CONTINUED CHALLENGING MARKETapril–june 2022 · Sales volume amounted to 5,371 (6,100 tonnes) a decline by 12%. · Net sales amounted to SEK 267.1 (246.3) million, an increase by 8%. The organic increase was 5%. · Operating profit amounted to SEK 13.5 (23.7) million, a decline by 43%. The adjusted operating profit amounted to SEK 13.5 (26.4) million, a decline by 49%. · The operating margin declined to 5.0% (9.6%) and adjusted operating margin declined to 5.0% (10.7%). · Profit for the period amounted to SEK 9.4 (18.6) million, a decline by 49%. ·

New patent approval in Hong Kong for Episurf Medical

The Intellectual Property Department (IPD) of Hong Kong has granted another patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Method and node for manufacturing a surgical kit for cartilage repair”, covers a medical image segmentation process for 3D visualisation of anatomical joints. “Image segmentation is a part of the technology around Episurf Medical’s individualised joint implants and surgical instruments. This patent adds on to previous patents within this area and broadens the protection for the company’s imaging technology in Hong Kong,”, says Katarina Flodström,

Nixu successfully pilots a Smart City digital service for the City of Jyväskylä together with IOXIO

Nixu Corporation, press release August 18, 2022 at 09:00 a.m. EESTNixu, together with IOXIO, has delivered a trusted data sharing pilot for the City of Jyväskylä. The pilot has been helping the City of Jyväskylä to establish an interoperable service infrastructure offered by a Smart City operator in the region. Nixu’s Identity and Access Management solution (IAM), together with IOXIO’s Dataspace service, has been successfully used in the first Smart City use case, which enables fully remote, easy, and secure control of access to both digital services as well as physical spaces. The

Interim report January – March 2022

Oslo, Norway, August 18, 2022 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the period January 1 – June 30, 2022. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Genetic Analysis CEO Ronny Hermansen comments:“As the first six months of 2022 have passed, I am proud to say that we keep on delivering on our objectives set out in the IPO. In the past quarter, we continued our preparation to expand globally to major markets and entered a strategic collaboration agreement

Publication of Orthex’s Half-Year Financial Report on 25 August 2022 and invitation to the result presentation on the same day

Orthex Corporation, Press release, 18 August 2022 at 9.00 a.m. EESTOrthex will publish its Half-Year Financial Report for the period January−June 2022 on Thursday, 25 August 2022 at around 09:00 a.m. EEST.Orthex’s CEO Alexander Rosenlew and CFO Saara Mäkelä will present the report on the same day at 11:00 a.m. EEST in a webcast. The webcast can be joined through this link 

There are no items matching the current filter
There are no more items matching the current filter
Back to top